Aroa Biosurgery Ltd
ASX:ARX

Watchlist Manager
Aroa Biosurgery Ltd Logo
Aroa Biosurgery Ltd
ASX:ARX
Watchlist
Price: 0.74 AUD 8.82% Market Closed
Market Cap: 255.2m AUD
Have any thoughts about
Aroa Biosurgery Ltd?
Write Note

Aroa Biosurgery Ltd
Investor Relations

Aroa Biosurgery Ltd. engages in the development of products for wound care and soft tissue regeneration. The firm is engaged in commercializing regenerative tissue substitutes for medical conditions where impaired healing leads to serious consequences for patients. The company designs and manufactures medical products which enable surgeons and clinicians to repair serious tissue injuries. The Company’s solutions include Endoform platform, Wound Care Portfolio and Reinforced Bioscaffolds. The Endoform platform is a building block for developing a range of regenerative tissue substitutes to assist with tissue repair and healing. Its wound care products comprise extracellular matrix to manage acute and chronic wounds. The Reinforced Bioscaffolds combine the biologics and synthetics to address the surgical ventral hernia repair solutions.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Dr. Brian Ward B.V.Sc, MBA(dist)
Founder, CEO, MD & Executive Director
No Bio Available
Mr. James Agnew BCom, LLB
CFO & Joint Company Secretary
No Bio Available
Mr. Rod Stanley M.Sc.
Chief Technology Officer
No Bio Available
Dr. Barnaby C.H. May Ph.D.
Chief Scientific Officer
No Bio Available
Ms. Neetha Alex-Kumar
General Counsel
No Bio Available
Mr. Frazer Murray
Director of Global Marketing & Strategy
No Bio Available
Ms. Yasmin Winchester B.Sc.
Vice President of Quality, Regulatory & Sustainability
No Bio Available
Ms. Tracy Weimar BA, MBA
Joint Company Secretary
No Bio Available
Mr. Adam Young Ph.D.
Vice President of Medical Affairs
No Bio Available

Contacts

Address
AUCKLAND
64 Richard Pearse Drive, Mangere
Contacts
+6498693035.0
aroabio.com